Spondyloarthritis: when the inflammation is controlled and the pain is not.
Your bloods look better, your scans look quiet, and your back still hurts. There is a reason for that, and it is treatable.
Spondyloarthritis (including axial spondyloarthritis and ankylosing spondylitis) is inflammation of the joints between the bones of the spine, and sometimes the sacroiliac joints and other joints. It is a genuine inflammatory disease, not a neuroplastic one. But the ATNS Index of Neuroplastic Symptoms notes that in some people neuroplastic symptoms contribute to the pain, especially when the course over time or the response to treatment is not typical. The index also warns that the diagnosis is sometimes made on loose criteria without confirming blood tests, x-rays or MRI of the sacrum. Research shows that around half of people with axial spondyloarthritis score high for central sensitization, a sensitized nervous system that keeps producing pain even when inflammation is controlled. An approach exists that addresses that part of the problem.
This page is about understanding the condition and the role the brain and nervous system can play in it. It is not a diagnosis. Your own clinicians know your case.
What spondyloarthritis is
Arthritis means inflammation of a joint. Spondyloarthritis means inflammation of the joints between the vertebrae, the bones of the spine. The best-known form is ankylosing spondylitis, and the broader modern term is axial spondyloarthritis (axSpA). It often begins in young adulthood with back pain and stiffness that is worse in the morning and after rest, and better with movement. Many people also have sacroiliac joint inflammation, and some have inflammation in peripheral joints, tendons, the eyes or the gut.
The diagnosis should rest on firm ground: a typical history, blood tests (inflammatory markers and the HLA-B27 gene), x-rays, and MRI of the sacroiliac joints. Treatment with anti-inflammatory drugs and, when needed, biologic medicines can be very effective at controlling inflammation.
Here is the first thing to know. The ATNS Index of Neuroplastic Symptoms flags that this diagnosis is sometimes made on loose criteria, without the tests that confirm or rule it out. If you were told you have spondyloarthritis but never had imaging of the sacrum or the relevant blood tests, it is reasonable to ask your rheumatologist to confirm the diagnosis properly.
The neuroplastic contribution
The ATNS index is direct: spondyloarthritis is not caused by neuroplastic symptoms. But in some patients neuroplastic symptoms contribute to the pain, and this is especially likely when the course over time or the response to treatment is not what you would expect.
Neuroplastic symptoms are real symptoms produced by learned pathways in the brain and nervous system rather than by ongoing damage or disease. The nervous system works like an alarm. When pain has been present for months or years, the alarm can become sensitized: it fires more easily, more widely and more loudly than the tissue warrants. Researchers call this central sensitization or nociplastic pain (see the three types of chronic pain). The pain is not imaginary, not a character flaw, and not permanent, because the brain that learned it can also unlearn it.
In spondyloarthritis this shows up as:
- Pain that stays high even when inflammatory markers and MRI show the disease is quiet.
- Pain spreading beyond the spine and sacroiliac joints to a widespread pattern.
- Fatigue, poor sleep and brain fog that do not track with disease activity.
Fear, catastrophic thinking about the spine fusing, and avoiding movement all feed the sensitized alarm. That is the fear-avoidance cycle, and in a condition where movement is medicine, it matters a great deal.
What the research shows
A study of the Central Sensitization Inventory in people with axial spondyloarthritis found that a large share of patients, in the range of 45 to 60 percent across studies, scored at or above the threshold that suggests central sensitization. Those with high scores had higher disease activity scores and lower quality of life, even though those scores are meant to measure inflammation.
A study of people with axial spondyloarthritis already receiving biologic disease-modifying drugs looked at those who still had residual symptoms. It found that nociplastic and neuropathic pain components were associated with ongoing symptoms despite treatment that was controlling inflammation. In plain terms: when the biologic is doing its job and pain persists, the nervous system is often the reason.
A third study examined the many contributors to disease burden in axial spondyloarthritis and found that central sensitization, pain catastrophizing and sleep disturbance all independently predicted worse outcomes. These are exactly the factors that a brain-based approach targets.
Honest limits: these are mostly cross-sectional studies, there is no gold-standard test for central sensitization, and the questionnaires used overlap with symptoms of fibromyalgia, which is itself common in spondyloarthritis. But the direction of the evidence is consistent.
Signs the nervous system may be part of the picture
- Your rheumatologist says the disease is well controlled, but your pain has not improved to match.
- Pain has spread to areas that were never inflamed, or feels widespread and shifting.
- Your pain gets worse with stress, poor sleep or emotional strain more than with activity.
- You have had several medication changes without a clear benefit.
- You have stopped exercising because you are afraid of damaging your spine.
Walk and track, four minutes
Take a slow four-minute walk, indoors if you like. For the first minute, notice the stiffness or ache in your back without trying to change it. Describe it to yourself in neutral words: warm, tight, dull, pulsing. For the next two minutes, keep walking and remind yourself, calmly, that your inflammation is being treated and that this sensation is a signal, not a sign of damage. Let your shoulders drop. For the last minute, notice whether the sensation has shifted at all. It may not, and that is fine. The practice is about meeting the sensation with less alarm, and repeating that daily is how a sensitized system settles.
A solution that addresses it
There is an approach designed for the brain's contribution to pain. It is often called pain reprocessing, and it combines education about neuroplastic symptoms, somatic tracking (attending to sensations with curiosity rather than fear), reducing the sense of threat around pain, a graded return to movement, emotional awareness and expression, and acceptance and commitment skills. Trained clinicians deliver it, and it is increasingly available through digital programs. It does not replace your rheumatology treatment.
Cindra is a daily AI companion built around these approaches, with daily check-ins, short practices and plain-language lessons for people whose symptoms have a neuroplastic component. If your pain has outrun your inflammation, you can join the waitlist.
What to do next
Start by making sure the diagnosis is solid. Ask whether you have had HLA-B27 and inflammatory blood tests, x-rays, and an MRI of the sacroiliac joints. If not, ask for them. Keep taking your prescribed medication; do not stop anything on your own.
Next, ask your rheumatologist a specific question: given my current test results, how much of my pain do you think is inflammation and how much might be a sensitized nervous system? Many rheumatologists now screen for central sensitization and will welcome the question.
If part of your pain fits a neuroplastic pattern, begin learning and practising. Understanding why chronic pain persists and why hurt is not the same as harm are good first steps, followed by gentle, regular movement.
Seek prompt medical attention for new eye pain or redness, sudden severe pain after a fall, fever with back pain, new weakness or numbness in the legs, or loss of bladder or bowel control.
Questions people ask
Is spondyloarthritis a neuroplastic condition?
No. The ATNS index says spondyloarthritis is not caused by neuroplastic symptoms. But it notes that in some people neuroplastic symptoms add to the pain, particularly when the course or the response to treatment is not typical. Research suggests this applies to a large share of patients.
How do I know whether my diagnosis is confirmed?
A confirmed diagnosis usually involves inflammatory blood tests, the HLA-B27 gene test, x-rays, and an MRI of the sacroiliac joints, together with a typical history. The ATNS index warns that the label is sometimes given on loose criteria. Ask your clinician which of these you have had.
If my pain is partly neuroplastic, should I stop my biologic?
No. Keep taking your prescribed treatment and discuss any changes with your rheumatologist. A brain-based approach is added alongside medical care, not instead of it.
References
- Value of the central sensitisation inventory in patients with axial spondyloarthritis. PMC11590847
- Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs. PMC10875534
- Multidimensional contributors to disease burden in axial spondyloarthritis: role of central sensitization, catastrophizing and sleep disturbance. PMC13488833
A daily companion for the hard days and the ordinary ones.
Cindra is an AI companion from Karuna Labs built around acceptance and commitment therapy and the science of neuroplastic symptoms. It checks in with you each day, helps you notice what your symptoms are pulling you away from, and nudges you back toward the things that matter. Cindra is invite-only while we build it with early members.
Join the waitlistThis article is for general education and is not medical advice, and it does not diagnose or treat any condition. Persistent symptoms deserve a proper medical assessment to rule out disease or injury before a neuroplastic explanation is considered. If your symptoms are new, changing, or come with red-flag signs such as fever, unexplained weight loss, numbness or weakness, chest pain, or loss of bladder or bowel control, see a clinician promptly.